S. Korean Drug Makers See Potential Gold In Developing Biosimilars
This article was originally published in PharmAsia News
Executive Summary
South Korean drug makers are jumping into the business of developing biosimilars with an expectation the market will become a large and lucrative one within the next 10 years.